456 related articles for article (PubMed ID: 21929465)
1. Pharmacokinetic evaluation of frovatriptan.
Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
[TBL] [Abstract][Full Text] [Related]
2. Frovatriptan review.
Markus F; Mikko K
Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of almotriptan for the treatment of migraines.
Negro A; Lionetto L; D'Alonzo L; Casolla B; Marsibilio F; Vignaroli G; Simmaco M; Martelletti P
Expert Opin Drug Metab Toxicol; 2013 May; 9(5):637-44. PubMed ID: 23570251
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
Savi L; Mogavero S; Egan CG
Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
[TBL] [Abstract][Full Text] [Related]
5. Frovatriptan: a review of its use in the acute treatment of migraine.
Sanford M
CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
Guidotti M; Ravasio R
Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
[TBL] [Abstract][Full Text] [Related]
7. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
Elkind AH; MacGregor EA
Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
9. Frovatriptan.
Easthope SE; Goa KL
CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
[TBL] [Abstract][Full Text] [Related]
10. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
Cady RK; Banks J; Jones BA; Campbell J
Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
Allais G; Rolando S; De Lorenzo C; Benedetto C
Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines.
Lionetto L; Casolla B; Mastropietri F; D'Alonzo L; Negro A; Simmaco M; Martelletti P
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):1043-50. PubMed ID: 22762358
[TBL] [Abstract][Full Text] [Related]
13. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.
Géraud G; Keywood C; Senard JM
Headache; 2003 Apr; 43(4):376-88. PubMed ID: 12656709
[TBL] [Abstract][Full Text] [Related]
14. [Frovatriptan possibly causing acute myocardial infarction].
Møller-Helgestad OK; Kaltoft AK; Kasch H
Ugeskr Laeger; 2015 Mar; 177(13):V10140537. PubMed ID: 25822816
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
Allais G; Benedetto C
Drug Des Devel Ther; 2016; 10():3225-3236. PubMed ID: 27757013
[TBL] [Abstract][Full Text] [Related]
16. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
Göbel H; Heinze A
Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
[TBL] [Abstract][Full Text] [Related]
17. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
[TBL] [Abstract][Full Text] [Related]
18. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
Balbisi EA
Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
[TBL] [Abstract][Full Text] [Related]
19. Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.
Franconi F; Finocchi C; Allais G; Omboni S; Tullo V; Campesi I; Reggiardo G; Benedetto C; Bussone G
Neurol Sci; 2014 May; 35 Suppl 1(Suppl 1):99-105. PubMed ID: 24867845
[TBL] [Abstract][Full Text] [Related]
20. Triptans for the management of migraine.
Johnston MM; Rapoport AM
Drugs; 2010 Aug; 70(12):1505-18. PubMed ID: 20687618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
